Novo Nordisk A/S: FDA Discloses Focus of Advisory Committee Meeting on Insulin Degludec and Insulin Degludec/Insulin Aspart

BAGSVAERD, DENMARK--(Marketwire - October 25, 2012) -

Company announcement No 68 / 2012:

http://hugin.info/2013/R/1652555/533479.pdf

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
    other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
     originality of the information contained therein.
    

[HUG#1652555]